Clinical Trials Logo

Filter by:
NCT ID: NCT01482858 Withdrawn - Osteoporosis Clinical Trials

Analgesic Effects of the Gastrolith, in Osteoporotic Patients Suffering From Recent Skeletal Pain Caused by Vertebral Fractures

Start date: December 2011
Phase: N/A
Study type: Interventional

This study aims to evaluate the safety and analgesic effect (efficacy) of Gastrolith powder (GASP) on skeletal pain caused by osteoporotic vertebral compression fractures (OVCF) versus placebo, primarily as assessed by the Numeric Rating Scale (NRS), and Brief Pain Inventory (BPI). It is also intended to evaluate disability change with the Oswestry Low Back Pain Disability Index (ODI) and to evaluate whether GASP consumption leads to reduction in analgesic standard of care (ASOC) versus placebo, using weekly analgesic consumption diaries.

NCT ID: NCT01477788 Withdrawn - Ovarian Neoplasm Clinical Trials

Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass

Start date: May 2011
Phase: N/A
Study type: Observational

The objective of the study is to create a test that will discriminate between malignant and benign ovarian mass that was diagnosed by ultrasound. The investigators will examine about 800 women and at the end of the study the investigators will combine data from the woman's history, the sonographic characters of the mass and serum biological markers along with the woman's outcome (which means - whether the mass was malignant, benign, or disappeared or remained constant with no intervention).

NCT ID: NCT01467830 Withdrawn - Inguinal Hernia Clinical Trials

Open Inguinal Hernia Repair With Mesh,the Use of Absorbable Versus Non Absorbable Fixation Sutures

Start date: December 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of mesh fixation using absorbable versus non-absorbable sutures.

NCT ID: NCT01455480 Withdrawn - Clinical trials for Partial Thickness Burn

Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn

Start date: December 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this Trial is to evaluate the performance of RPh201 as a treatment for the healing of partial thickness burns. It is further postulated that deep second degree lesions will benefit from the RPh201 treatment promoting granulation and epithelialization as well as wound closure.

NCT ID: NCT01450241 Withdrawn - Febrile Neutropenia Clinical Trials

Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia

Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether short-course antibiotic therapy is safe and effective for the treatment of cancer patients with febrile neutropenia.

NCT ID: NCT01448499 Withdrawn - Schizophrenia Clinical Trials

Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients

ClozAmi
Start date: October 2011
Phase: N/A
Study type: Interventional

Background: schizophrenia is a debilitating mental disorder affecting about 1% of the general population. About 30% of patients will not react to current drug treatment and defined as treatment-resistant schizophrenia patients (TRSP). The best studied therapeutic option for this population is clozapine therapy. Clozapine was shown to be effective than any other antipsychotic drug in TRSP. Moreover, augmentation of clozapine was not demonstrated to be more effective than clozapine monotherapy. Albeit Clozapine superiority in TRSP, its use may be involved with many adverse effects, some of them are life-threatening, and need for routine blood tests. Amisulpride is an atypical antipsychotic drug with a different mechanism of action than clozapine, with less adverse effects. No study compared directly amisulpride and clozapine in TRSP. Study objective: to compare, for the first time, the broad clinical effectiveness of clozapine and amisulpride and their combination in TRSP. Study Design: a clinical, prospective, naturalistic, randomized, comparative study simulating a real-world approach of clinical decision making. Methods: a total of 140 TRSP will be recruited from a large regional mental health center. Participants will be randomized into two treatment groups (70 in each group): clozapine monotherapy and amisulpride monotherapy. Assessment will be done following 10 and 20 weeks of treatment. In case of treatment failure (insufficient clinical response or severe adverse effect) participants will be offered either to switch to clozapine treatment (for failed amisulpride treatment) or to augment clozapine with amisulpride (for failed clozapine monotherapy patients). Thereafter, participants will be followed-up for a year. Assessment will be made using clinician rated scales and self-completed questionnaires, rating the broad phenomenology of schizophrenia (psychosis, mood, anxiety, obsessive-compulsive, cognitive and quality of life) and drug-related adverse effects (objective and subjective). Analysis: comparison of the effectiveness of the three treatment groups: amisulpride, clozapine and their combination, in the various dimensions of TRSP.

NCT ID: NCT01430000 Withdrawn - Hepatitis C Clinical Trials

Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

Patients who completed the conventional treatment against HCV and relapsed (the virus appeared again in their blood) have no effective therapy.

NCT ID: NCT01425255 Withdrawn - Type 1 Diabetes Clinical Trials

The Impact of Continuous Glucose Monitoring Use on Sleep in Parents of Children With Type 1 Diabetes Mellitus

Start date: August 2011
Phase: N/A
Study type: Observational

The purpose of this prospective exploratory study is to compare sleep quality and sleep-wake patterns in parents of children with type 1 diabetes (T1D) before and several weeks after initiating using real-time continuous glucose monitoring (RT-CGM) of their children.

NCT ID: NCT01421823 Withdrawn - Clinical trials for Idiopathic Fecal Incontinence

A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence

Start date: August 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the effect and safety of alpha agonist ointment on fecal incontinence severity in patients with idiopathic fecal incontinence.

NCT ID: NCT01387685 Withdrawn - Clinical trials for Pelvic Floor Prolapse

Treatment of Pelvic Organ Prolapse by PIVS Versus Surgeon Cut Mesh

Start date: February 2009
Phase: N/A
Study type: Observational

Women with pelvic floor prolapse who underwent surgery with mesh will be enrolled. The investigators will compare data from the chart, telephone interviews and physical examinations between those who underwent mesh placement to those who underwent placement of PIVS.